Holen Sie sich die Stockscreener-App
2.05
17.34%
-0.43
Handel nachbörslich:
2.07
0.02
+0.98%
Schlusskurs vom Vortag:
$2.48
Offen:
$2.45
24-Stunden-Volumen:
540.05K
Relative Volume:
1.44
Marktkapitalisierung:
$108.05M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.1017
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
+17.82%
1M Leistung:
+28.93%
6M Leistung:
+28.93%
1J Leistung:
-20.39%
1-Tages-Spanne:
$2.045
$2.45
1-Wochen-Bereich:
$1.6907
$2.58
52-Wochen-Spanne:
$1.09
$3.40
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.05 | 130.71M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Is Cibus Inc. stock attractive for long term wealth buildingSwing Trade & Fast Entry High Yield Stock Tips - ulpravda.ru
Why Cibus Inc. stock attracts global investorsWeekly Stock Analysis & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru
Cibus repurchases shares from employee in board-approved transaction By Investing.com - Investing.com India
Cibus repurchases shares from employee in board-approved transaction - Investing.com
Cibus executes minor internal Class A share repurchase - TipRanks
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America - AgriBusiness Global
Cibus And Interoc Sign LOI To Advance Herbicide-Tolerant Rice Commercialization In Latin America - iGrow News
Retail Trends: Why Cibus Inc stock is a must watch in 2025Weekly Market Outlook & Daily Profit Maximizing Tips - moha.gov.vn
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America By Investing.com - Investing.com South Africa
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance
Cibus (CBUS) and Interoc Plan Commercialization of Herbicide-Tol - GuruFocus
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America - Investing.com
Cibus and Interoc Advance Rice Commercialization Strategy - GlobeNewswire
Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Decreases By 32.9% - MarketBeat
Stock Market Recap: Why Cibus Inc stock is a must watch in 20252025 Volatility Report & Verified Short-Term Plans - moha.gov.vn
Will Cibus Inc. stock pay special dividendsWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Cibus (CBUS) EV-to-OCF : -1.87 (As of Dec. 19, 2025) - GuruFocus
How Cibus Inc. stock responds to policy changesJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
Craig Wichner Net Worth (2025) - GuruFocus
Will Cibus Inc. stock attract more institutional investorsEarnings Beat & Short-Term Trading Alerts - bolumsonucanavari.com
Guidance Update: Is Cibus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - Улправда
Is Cibus Inc. stock recession proof2025 Bull vs Bear & Weekly Market Pulse Alerts - Улправда
Gratia Capital LLC Acquires New Shares in Cibus, Inc. $CBUS - MarketBeat
Cibus director Prante sells $2,875 in stock - MSN
Signal Recap: Can Cibus Inc stock maintain growth trajectory2025 Macro Impact & Weekly Return Optimization Alerts - moha.gov.vn
CBUS FinancialsIncome Statement - Quiver Quantitative
Cibus (CBUS) Applauds EU Agreement on Gene-Edited Plant Regulati - GuruFocus
Cibus Welcomes EU Political Agreement on New Genomic Techniques, Supporting Advances in Plant Breeding Innovation - Quiver Quantitative
Cibus (Nasdaq: CBUS) sees EU NGT agreement advancing gene-edited plant rules - Stock Titan
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council - The Manila Times
Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail
Cibus’ (CBUS) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World
Is Cibus Stock Built to Withstand a Pullback? - Trefis
Canaccord Genuity Maintains Cibus (CBUS) Buy Recommendation - Nasdaq
Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus
Cibus (NASDAQ:CBUS) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
ETFs Investing in Cibus, Inc. Stocks - TradingView — Track All Markets
What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in
Cibus (CBUS) Total Equity : $52.03 Mil (As of Sep. 2025) - GuruFocus
Cibus (NASDAQ:CBUS) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE:LND) Critical Review - Defense World
Insider Sell: How Cibus Inc. stock responds to policy changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus CBUS grants director 45,627 options expiring in 2035 - Stock Titan
[Form 3] Cibus, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cibus (CBUS) Other Stockholders Equity : $0.00 Mil (As of Sep. 2025) - GuruFocus
Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
What is the fair value of Cibus Inc. stock nowMarket Risk Report & Reliable Trade Execution Plans - newser.com
Is Cibus Inc. stock overvalued by current metricsPrice Action & AI Driven Stock Movement Reports - newser.com
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):